Urology Case Reports (Jan 2022)

Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas

  • David Strauss,
  • Andres Correa,
  • Yulan Gong,
  • Andreas Karachristos,
  • Alexander Kutikov

Journal volume & issue
Vol. 40
p. 101950

Abstract

Read online

Paragangliomas are rare neuroendocrine tumors that can vary in size and metabolic activity. We report a case of giant bilateral malignant retroperitoneal paragangliomas (PGL) in a patient with germline succinate dehydrogenase B (SDHB) mutation. This patient, who presented in an emaciated and debilitated state, was managed with adrenergic blockade followed by radical primary surgery. After being metabolically and radiographically disease free for 4 years, he underwent salvage resection for recurrent retroperitoneal disease and palliative radiation to a site of solidary vertebral metastasis. We review incidence and prognosis of metastatic PGL.

Keywords